drugset / Trial / NCT00305448
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will assess the relationship between fulvestrant dose and efficacy, and determine the dosing regimen as a second line therapy for Japanese postmenopausal women with oestrogen receptor positive advanced breast cancer.
Timeline
- Start
- 2006-03
- Primary completion
- 2008-03
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fulvestrant | Small molecule | 250 mg | Intramuscular |
| Subject | Fulvestrant | Small molecule | 500 mg | Intramuscular |